| Q90419746 | A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity |
| Q36315020 | Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma |
| Q64107824 | Cytarabine-Resistant -ITD Leukemia Cells are Associated with Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib |
| Q36778468 | Effects of somatic mutations are associated with SNP in the progression of individual acute myeloid leukemia patient: the two-hit theory explains inherited predisposition to pathogenesis |
| Q42287089 | Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML |
| Q36075226 | High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia |
| Q36511384 | MicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients |
| Q36962978 | Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1 |
| Q34528361 | SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study |
| Q64052506 | Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine |
| Q34038636 | Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia |
| Q36180934 | Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML |
| Q35467835 | Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance |